Halo Neuro
Latest round
- Series B
Last raised
- Nov 2017
Total raised
- $24M
Investors
- 7
About Halo Neuro
Founded in 2013 and headquartered in San Francisco, US, Halo Neuro, Inc. is dedicated to pioneering neurotechnology.Halo Neuro specializes in advanced neurotechnology solutions, focusing on the development and application of neurostimulation devices designed to address various neurological conditions. Their flagship product is a non-invasive neurostimulation device that employs technologies to modulate brain activity, providing therapeutic benefits for conditions such as chronic pain, anxiety, and depression. Released in recent years, this product has garnered attention in both clinical and consumer markets, appealing to healthcare providers, rehabilitation centers, and individual users seeking alternative treatments. The company aims to enhance patient outcomes and quality of life by offering innovative solutions that are scientifically backed and user-friendly.Halo Neuro generates revenue through the sale of its neurostimulation devices and related services, employing a direct-to-consumer model alongside partnerships with healthcare providers. The company’s transactions typically involve clients purchasing their flagship products either outright or through subscription-based models for ongoing access to software updates and additional services. This structure facilitates a steady revenue stream while encouraging continuous engagement with users through follow-up services and enhancements. Pricing plans for their devices accommodate both individual consumers and institutional clients, allowing for scalable solutions that meet varying needs. The company is targeting new geographic regions in North America and Europe, with strategic plans to introduce additional therapies aimed at addressing a broader range of neurological conditions. Additionally, the funds will support research and development efforts to enhance existing product lines and potentially explore new applications of neurotechnology.
Who invested in Halo Neuro
7 investors across 4 rounds
See all investors in Halo Neuro
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Halo Neuro
Who invested in Halo Neuro?
Halo Neuro has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Halo Neuro raised?
Halo Neuro has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Halo Neuro last raise money?
Halo Neuro's most recent round on record is a Series B, in Nov 2017.
What does Halo Neuro do?
Founded in 2013 and headquartered in San Francisco, US, Halo Neuro, Inc.
Where is Halo Neuro headquartered?
Halo Neuro is headquartered in San Francisco, US.
Which VCs invest in companies like Halo Neuro?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back consumer products companies at Halo Neuro's stage. Their profiles are linked below.
VCs backing consumer products startups at Series B
Raising like Halo Neuro? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.